Cargando…
The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study
PURPOSE: High-risk patients with stage II colon cancer (CC) may benefit from adjuvant chemotherapy, but additional prognostic markers are needed for better stratification. We investigated the prognostic value of tumour stroma ratio (TSR) and tumour budding (TB). METHODS: A nationwide population-base...
Autores principales: | Eriksen, Ann Christina, Sørensen, Flemming B., Lindebjerg, Jan, Hager, Henrik, dePont Christensen, René, Kjær-Frifeldt, Sanne, Hansen, Torben F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060800/ https://www.ncbi.nlm.nih.gov/pubmed/29785462 http://dx.doi.org/10.1007/s00384-018-3076-9 |
Ejemplares similares
-
Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
por: Eriksen, Ann C., et al.
Publicado: (2018) -
The Prognostic Value of Tumor-Infiltrating lymphocytes in Stage II Colon Cancer. A Nationwide Population-Based Study()
por: Eriksen, Ann C., et al.
Publicado: (2018) -
Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort
por: Eriksen, Ann C., et al.
Publicado: (2019) -
Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts
por: Hansen, Torben Frøstrup, et al.
Publicado: (2018) -
Computer-assisted stereology and automated image analysis for quantification of tumor infiltrating lymphocytes in colon cancer
por: Eriksen, Ann C., et al.
Publicado: (2017)